Analysis of Vis–NIR spectra changes to measure the inflammatory response in the nasal mucosal region of influenza A and B virus-infected patients

Sakudo, Akikazu; Baba, Koichi; Ikuta, Kazuyoshi

doi:10.1016/j.jcv.2012.08.015

Cited by 9 publications

(6 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite this, several lines of evidence exist suggesting these viruses are also capable of causing significant human disease. Comparative human clinical reports suggest that influenza B infection may induce severe clinical and inflammatory responses comparable to influenza A (Kaji et al , 2003; Sakudo et al , 2012). Influenza B virus dominant seasons have also been documented such as the 2002–2003 season when the prevalence of influenza B infection was higher than that of influenza A infection in most countries around the world.…”

Section: Introductionmentioning

confidence: 99%

Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection

Huang

Banner

Paquette

et al. 2014

Journal of General Virology

View full text Add to dashboard Cite

Influenza B viruses have become increasingly more prominent during influenza seasons. Influenza B infection is typically considered a mild disease and receives less attention than influenza A, but has been causing 20 to 50 % of the total influenza incidence in several regions around the world. Although there is increasing evidence of mid to lower respiratory tract diseases such as bronchitis and pneumonia in influenza B patients, little is known about the pathogenesis of recent influenza B viruses. Here we investigated the clinical and pathological profiles of infection with strains representing the two current co-circulating B lineages (B/Yamagata and B/Victoria) in the ferret model. Specifically, we studied two B/Victoria (B/Brisbane/60/2008 and B/Bolivia/1526/2010) and two B/Yamagata (B/Florida/04/2006 and B/Wisconsin/01/2010) strain infections in ferrets and observed strain-specific but not lineage-specific pathogenicity. We found B/Brisbane/60/2008 caused the most severe clinical illness and B/Brisbane/60/2008 and the B/Yamagata strains instigated pathology in the middle to lower respiratory tract. Importantly, B/Brisbane/60/2008 established efficient lower respiratory tract infection with high viral burden. Our phylogenetic analyses demonstrate profound reassortment among recent influenza B viruses, which indicates the genetic make-up of B/Brisbane/60/2008 differs from the other strains. This may explain the pathogenicity difference post-infection in ferrets.

show abstract

Section: Introductionmentioning

confidence: 99%

Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection

Huang

Banner

Paquette

et al. 2014

Journal of General Virology

View full text Add to dashboard Cite

show abstract

“…Disease symptoms caused by an influenza B virus infection are remarkably similar to those caused by influenza A virus infections and include fever, cough, abdominal pain, headache, vomiting and conjunctivitis [12,[73][74][75][76][77]. Since the vast majority of influenza B virus infections are not fatal, it is difficult to study pathological changes induced by infection in humans.…”

Section: Influenza B Virus-related Pathological Changesmentioning

confidence: 99%

Influenza B Viruses: Not to be Discounted

et al. 2015

View full text Add to dashboard Cite

In contrast to influenza A viruses, which have been investigated extensively, influenza B viruses have attracted relatively little attention. However, influenza B viruses are an important cause of morbidity and mortality in the human population and full understanding of their biological and epidemiological properties is imperative to better control this important pathogen. However, some of its characteristics are still elusive and warrant investigation. Here, we review evolution, epidemiology, pathogenesis and immunity and identify gaps in our knowledge of influenza B viruses. The divergence of two antigenically distinct influenza B viruses is highlighted. The co-circulation of viruses of these two lineages necessitated the development of quadrivalent influenza vaccines, which is discussed in addition to possibilities to develop universal vaccination strategies.

show abstract

“…The symptoms of the virus infection affect the molecular compositions that result in observing a specific signature in the spectral characteristics of the infected samples that are used for the illness diagnosis. NIRS has been employed successfully for detecting viruses in humans such as hepatitis C, HIV, and influenza [24][25][26][27][28]. The ability of the NIRS to distinguish between normal and virus-infected specimens in a short time with good accuracy, suggests that NIRS is a promising technology in virology [15,25,29,30].…”

Section: Introductionmentioning

confidence: 99%

Near-Infrared Spectroscopy as a Potential COVID-19 Early Detection Method: A Review and Future Perspective

Raypah

Faris

Azlan

et al. 2022

Sensors

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic is a worldwide health anxiety. The rapid dispersion of the infection globally results in unparalleled economic, social, and health impacts. The pathogen that causes COVID-19 is known as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A fast and low-cost diagnosis method for COVID-19 disease can play an important role in controlling its proliferation. Near-infrared spectroscopy (NIRS) is a quick, non-destructive, non-invasive, and inexpensive technique for profiling the chemical and physical structures of a wide range of samples. Furthermore, the NIRS has the advantage of incorporating the internet of things (IoT) application for the effective control and treatment of the disease. In recent years, a significant advancement in instrumentation and spectral analysis methods has resulted in a remarkable impact on the NIRS applications, especially in the medical discipline. To date, NIRS has been applied as a technique for detecting various viruses including zika (ZIKV), chikungunya (CHIKV), influenza, hepatitis C, dengue (DENV), and human immunodeficiency (HIV). This review aims to outline some historical and contemporary applications of NIRS in virology and its merit as a novel diagnostic technique for SARS-CoV-2.

show abstract

Analysis of Vis–NIR spectra changes to measure the inflammatory response in the nasal mucosal region of influenza A and B virus-infected patients

Cited by 9 publications

References 15 publications

Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection

Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection

Influenza B Viruses: Not to be Discounted

Near-Infrared Spectroscopy as a Potential COVID-19 Early Detection Method: A Review and Future Perspective

Contact Info

Product

Resources

About